Daniel Winter Goodman
Founder at Psychogenics, Inc.
Daniel Winter Goodman active positions
| Companies | Position | Start | End |
|---|---|---|---|
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Director/Board Member | 1999-12-31 | - |
| Founder | 1997-12-31 | - | |
| Chief Executive Officer | 1997-12-31 | 1999-12-31 | |
| Riverside Pharmaceuticals Corp. | Chief Executive Officer | 2011-12-31 | - |
| Founder | 2011-12-31 | - | |
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
| The Midtown Practice For Psychotherapy & Psychiatry | Founder | 2016-12-31 | - |
| President | 2016-12-31 | - | |
| Daniel Goodman MD PC | Founder | 2002-12-31 | - |
| President | 2002-12-31 | - |
Career history of Daniel Winter Goodman
Former positions of Daniel Winter Goodman
| Companies | Position | Start | End |
|---|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Director/Board Member | 2019-05-05 | 2022-05-05 |
| Independent Dir/Board Member | 2019-05-05 | 2022-05-05 | |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Founder | 2001-06-19 | - |
| President | 2001-06-19 | - |
Training of Daniel Winter Goodman
| Harvard Medical School | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
| Yale College | Undergraduate Degree |
Statistics
International
| United States | 11 |
Operational
| Founder | 5 |
| President | 3 |
| Director/Board Member | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Private companies | 5 |
|---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
| Riverside Pharmaceuticals Corp. | Miscellaneous |
| The Midtown Practice For Psychotherapy & Psychiatry | |
| Daniel Goodman MD PC |
